Fermenta Biotech Board of Directors
Get the latest insights into the leadership at Fermenta Biotech. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Pradeep Chandan | Non Executive Independent Director |
| Rajeshwari Datla | Non Executive Director |
| Pramod Kasat | Non Executive Independent Director |
| Rajashri Ojha | Non Executive Independent Director |
| Ramanand Mundkur | Non Executive Independent Director |
| Krishna Datla | Vice Chairman |
| Satish Varma | Whole Time Director |
| Anupama Datla Desai | Whole Time Director |
| Prashant Nagre | Managing Director |
| Varadvinayak Vijay Khambete | Company Secretary & Compliance Officer, Head - Legal |
Fermenta Biotech FAQs
The board at Fermenta Biotech consists of experienced professionals, including Pradeep Chandan, Rajeshwari Datla, and others, overseeing the company’s strategic and corporate governance.
Directors at Fermenta Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Pradeep Chandan is the current chairman at Fermenta Biotech.
Executive directors at Fermenta Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Fermenta Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Fermenta Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
